Subtype
Rectal Neoplasm
CI-CAN-00006564Explore in graph →
Non-malignant434 active trials1 approved drugs5 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00006564Explore in graph →
Clinical trials
1,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05074082 | Perineal Flap Reconstruction Following Surgery for Advanced Pelvic Malignancy | completed | — | 883 | St Vincent's University Hospital, IrelandOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT04080414 | Home-based HIIT to Improve CRC Survivorship: Feasibility and Relationship With Novel Surrogate Biomarkers of CRC Recurrence | completed | N/A | 7 | University of UtahOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT03770689 | Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer | completed | Phase 1 / Phase 2 | 19 | EMD Serono Research & Development Institute, Inc.INDUSTRY | 2 | Mar 21, 2023 | clinicaltrials |
| NCT02399813 | A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal | completed | Phase 2 | 36 | Advaxis, Inc.INDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT03299660 | Avelumab With Chemoradiation in Locally Advanced Rectal Cancer | completed | Phase 2 | 37 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT05040646 | The Development of a Patient Reported Outcomes Measure Committed to the Watch-and-wait Program for Rectal Cancer | completed | — | 80 | Maastricht University Medical CenterOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT00534131 | Anterior Perineal Plane for Ultra Low Anterior Resection of the Rectum(APPEAR) | completed | N/A | 23 | Queen Mary University of LondonOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT03750461 | Stoma Closure and Reinforcement Trial(SCAR) | completed | N/A | 20 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT02890758 | Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 | completed | Phase 1 | 14 | Brenda Cooper, MDOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT00579579 | Functional Outcomes and Quality of Life in Patients Undergoing Surgery for Rectal Cancer | completed | — | 229 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT03871959 | Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma(CATRIPCA) | completed | Phase 1 | 54 | Centre Leon BerardOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT01444495 | Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer | completed | N/A | 154 | Jagiellonian UniversityOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT05723965 | Using Artificial Intelligence to Predict Rectal Cancer Outcomes | completed | — | 720 | Taichung Veterans General HospitalOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT03871790 | Peptide-based Immunization for Colon- and and Pancreas-carcinoma(PICOP-GLOBAL) | completed | — | 50 | CENTOGENE GmbH RostockINDUSTRY | 1 | Feb 10, 2023 | clinicaltrials |
| NCT03043729 | mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer | completed | Phase 2 | 119 | AIO-Studien-gGmbHOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT05638048 | Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients | completed | N/A | 270 | Junyan ZhaoOTHER | 1 | Feb 3, 2023 | clinicaltrials |
| NCT02728804 | S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer | completed | — | 380 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04476082 | Nutrition in Gastrointestinal Tumors(NutriGIT) | completed | — | 66 | University Medicine GreifswaldOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT05682794 | Transanal Versus Laparoscopic Total Mesorectal Excision: a Cohort | completed | — | 2,502 | Sun Yat-sen UniversityOTHER | 0 | Jan 12, 2023 | clinicaltrials |
| NCT03297710 | TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery | completed | Phase 1 | 7 | Mayo ClinicOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT05667259 | Prognostic Significance of Lymph Node Ratio in Rectal Cancer on Overall Survival | completed | — | 229 | South Valley UniversityOTHER | 1 | Dec 28, 2022 | clinicaltrials |
| NCT05406765 | Enhanced Recovery After Laparoscopic Colorectal Surgery | completed | Phase 4 | 10 | University Hospital of North NorwayOTHER | 1 | Dec 22, 2022 | clinicaltrials |
| NCT01975064 | Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane Anesthesia(CAN) | completed | Phase 4 | 5,774 | Uppsala UniversityOTHER | 3 | Dec 14, 2022 | clinicaltrials |
| NCT04009876 | A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer | completed | Phase 2 | 30 | Fundación de investigación HMOTHER | 1 | Dec 13, 2022 | clinicaltrials |
| NCT03057288 | Prospective Study Evaluating the Feasibility of Fiducial Markers Placement for Patients With Esophageal or Rectal Cancer(FIDECHO) | completed | N/A | 40 | Société Française d'Endoscopie DigestiveOTHER | 1 | Dec 5, 2022 | clinicaltrials |
| NCT05129215 | Development and Validation of The Post-RT LARS Prediction Model (PORTLARS)(PORTLARS) | completed | — | 901 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT02810652 | Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection | completed | N/A | 160 | Massachusetts General HospitalOTHER | 1 | Nov 22, 2022 | clinicaltrials |
| NCT05622357 | Prospective Study of Short Course Radiation Therapy Followed by Neoadjuvant Chemotherapy and Surgery in Locally Advanced Rectal Cancer | completed | Phase 2 | 51 | National Cancer Institute, EgyptOTHER | 1 | Nov 18, 2022 | clinicaltrials |
| NCT05610592 | Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status | completed | — | 480 | Sun Yat-sen UniversityOTHER | 1 | Nov 9, 2022 | clinicaltrials |
| NCT05609149 | MRI Features in Neoadjuvant Treatment Decisions for Patients With Rectal Cancer | completed | — | 480 | Sun Yat-sen UniversityOTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT04788368 | TRECA - TREatment of Colorectal Adenomas and Early Colorectal CAncer in Region Västra Götaland(TRECA) | completed | — | 300 | Sahlgrenska University HospitalOTHER | 1 | Nov 7, 2022 | clinicaltrials |
| NCT05607186 | Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute | completed | — | 59 | Singapore General HospitalOTHER | 0 | Nov 7, 2022 | clinicaltrials |
| NCT04678349 | The Role of Partial Hydrolyzed Guar Gum in High Stoma Output Management Among Cancer Patients With Ileostomy | completed | N/A | 29 | Universiti Putra MalaysiaOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT05266300 | Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. | completed | — | 722 | University of Southern DenmarkOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT02233374 | Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET(PRISM) | completed | N/A | 27 | Royal North Shore HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT03182179 | Efficacy of Ondansetron in LARS Treatment(Hodolar) | completed | N/A | 48 | Ente Ospedaliero Cantonale, BellinzonaOTHER | 1 | Oct 17, 2022 | clinicaltrials |
| NCT05572151 | Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer | completed | — | 7,694 | The Second Affiliated Hospital of Harbin Medical UniversityOTHER | 0 | Oct 7, 2022 | clinicaltrials |
| NCT04409990 | Shear Wave Elastography of Rectal Adenomas and Cancer | completed | N/A | 164 | Vejle HospitalOTHER | 1 | Oct 5, 2022 | clinicaltrials |
| NCT05539417 | Snapshot Rectumcarcinoom 2016 | completed | — | 3,107 | Amsterdam UMC, location VUmcOTHER | 0 | Sep 16, 2022 | clinicaltrials |
| NCT05534841 | Assessment of Complete Response MRI Criterion After Neoadjuvant Therapy in Locally Advanced Rectal Cancer | completed | — | 99 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Sep 10, 2022 | clinicaltrials |
| NCT04939103 | TRUS-FNA For The Prediction Of pCR After Neoadjuvant Treatment In Rectal Cancer | completed | — | 63 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Sep 1, 2022 | clinicaltrials |
| NCT05496270 | Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer | completed | — | 1,509 | Sun Yat-sen UniversityOTHER | 0 | Aug 11, 2022 | clinicaltrials |
| NCT05493930 | A Lymph Node Metastasis Predictor (LN-MASTER) in Rectal Cancer | completed | — | 6,578 | Peking Union Medical CollegeOTHER | 0 | Aug 9, 2022 | clinicaltrials |
| NCT02602327 | Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases | completed | Phase 1 | 21 | University of California, San FranciscoOTHER | 1 | Aug 1, 2022 | clinicaltrials |
| NCT05476341 | A Phase I Clinical Trial of Bevacizumab Injection | completed | Phase 1 | 98 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Jul 27, 2022 | clinicaltrials |
| NCT01648894 | Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer(GRECCAR6) | completed | Phase 3 | 265 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT02130427 | A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy | completed | N/A | 74 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 22, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Mar 31, 2023source: clinicaltrials